Sun Pharma (Netherlands) B.V. significant ownership

Add to watchlist

Sun Pharma (Netherlands) B.V. is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Sun Pharma (Netherlands) B.V. significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage

Compare quarters

Export Sun Pharma (Netherlands) B.V.'s holdings

CSVXLS